INFLUENCE OF GENDER IN DEVELOPING AUTOIMMUNE DISEASES (Review Article)

LUKA ABASHISHVILI; ANA GOGOLASHVILI; DIANA KERATISHVILI; MARIAM PESTVENIDZE

doi:10.52340/jecm.2022.02.13

INFLUENCE OF GENDER IN DEVELOPING AUTOIMMUNE DISEASES (Review Article)

Authors

LUKA ABASHISHVILI
ANA GOGOLASHVILI
DIANA KERATISHVILI
MARIAM PESTVENIDZE

DOI:

https://doi.org/10.52340/jecm.2022.02.13

Abstract

Autoimmune diseases and their management are one of the most challenging problems of modern society. These types of diseases are far more commonly seen in women than in men. We believe that understanding the reasons for the sex-based differences in autoimmune diseases can play a significant role in managing the patients. This review summarizes the most important contributors to gender-based disparity, such as the X chromosome, sex hormones, micro-RNA, and microbiota.

Downloads

Download data is not yet available.

Author Biographies

LUKA ABASHISHVILI

USMD program, Tbilisi State Medical University, Tbilisi, Georgia

ANA GOGOLASHVILI

USMD program, Tbilisi State Medical University, Tbilisi, Georgia

DIANA KERATISHVILI

USMD program, Tbilisi State Medical University, Tbilisi, Georgia

MARIAM PESTVENIDZE

USMD program, Tbilisi State Medical University, Tbilisi, Georgia

References

Rubtsova K, Marrack P, Rubtsov AV. Sexual dimorphism in autoimmunity. J Clin Invest 2015;125(6):2187-93.

Billi, AC, Kahlenberg, JM, Gudjonsson JE. Sex bias in autoimmunity. Current opinion in rheumatology 2019;31(1):53–61.

Ortona E, Pierdominici M, Maselli A, Veroni C, Aloisi F, Shoenfeld Y. Sex-based differences in autoimmune diseases. Ann Ist Super Sanita 2016;52(2):205-12.

Brooks WH, Renaudineau Y. Epigenetics and autoimmune diseases: The X chromosome-nucleolus nexus. Front Genet 2015; 6:22.

Sharma S, Eghbali M. Influence of sex differences on microRNA gene regulation in disease. Biology of sex differences 2014;5(1), 3.

Garieri M, Stamoulis G, Blanc X, et al. Extensive cellular heterogeneity of X inactivation revealed by single-cell allele-specific expression in human fibroblasts. Proc Natl Acad Sci 2018;115(51):13015-20.

Scofield RH, Bruner GR, Namjou B, et al. Klinefelter's syndrome (47, XXY) in male systemic lupus erythematosus patients: support for the notion of a gene-dose effect from the X chromosome. Arthritis Rheum 2008;58(8):2511-17.

Komm BS, Terpening C M, Benz D J, et al. Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells. Science 1988; 241:81-84.

Kaufman KM, Zhao J, Kelly JA, et al. Fine mapping of Xq28: both MECP2 and IRAK1 contribute to risk for systemic lupus erythematosus in multiple ancestral groups. Ann Rheum Dis 2013;72(3):437-44.

Liegeois A, Gaillard MC, Ouvre E, Lewin D. Microchimerism in pregnant mice. Transplant Proc 1981; 13:1250-52.

Chitnis T, Glanz B, Jaffin S, Healy B. 2009. Demographics of pediatric-onset multiple sclerosis In an MS center population from the Northeastern United States. Multiple Sclerosis 2009; 15:627-31.

Chitnis, T., 2013 Role of puberty in multiple sclerosis risk and course. Clinical Immunology 2013;149(2):192-200.

Brown MA, Su MA. An Inconvenient Variable: Sex Hormones and Their Impact on T Cell Responses. Journal of immunology 2019;202(7):1927-33.

Polan ML, Daniele A, Kuo A. Gonadal steroids modulate human monocyte interleukin1 (IL-1) activity. Fertil Steril 1988; 49:964-68.

Jørgensen KT, Rostgaard K, Bache I, et al. Autoimmune diseases in women with Turner's syndrome. Arthritis Rheum 2010;62(3):658-66.

Araneo BA, Dowell T, Diegel M, Daynes RA. Dihydrotestosterone exerts a depressive influence on the production of interleukin-4 (IL-4), IL-5, and gamma interferon but not IL-2 by activated murine cells. Blood 1991;78: 688-99.

Ngo ST, McCombe PA, Steyn FJ. Gender differences in autoimmune disease. Frontiers in Neuroendocrinology. 2014:347-69.

Ortona E, Delunardo F, Maselli A, Pierdominici M, Malorni W. Sex hormones and gender disparity in immunity and autoimmunity. Gender specific Medicine 2015;45-50.

Keith RC, Sokolove J, Edelman BL, et al. Testosterone is protective in the sexually dimorphic development of arthritis and lung disease in SKG mice. Arthritis and rheumatism 2013:65(6):1487–93.

Sicotte NL, Giesser BS, Tandon V, et al. Testosterone Treatment in Multiple Sclerosis: A Pilot Study. Arch Neurol 2007;64(5):683–88.

Zhou X, Jeker LT, Fife BT, et al (2008). Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity. The Journal of experimental medicine 2008;205(9),1983–91.

Dai R, Ahmed SA. MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases. Transl Res 2011;157(4):163-79.

Yuen G J. Autoimmunity in women: an eXamination of eXistingmodels. Clinical immunology 2020; 210:108270.

Dai R, Phillips RA, Zhang Y, Khan D, Crasta O, Ahmed SA. Suppression of LPS induced Interferon-gamma and nitric oxide in splenic lymphocytes by select estrogen-regulated microRNAs: a novel mechanism of immune modulation. Blood 2008;112(12):4591–97.

Elderman M, de Vos P, Faas M. Role of Microbiota in Sexually Dimorphic Immunity. Frontiers in Immunology 2018; 9:1018.

Rosenshine I, Finlay BB. Exploitation of host signal transduction pathways and cytoskeletal functions by invasive bacteria. Bioessays 1993;15(1):17-24.

Chen Y, Mathews C, Driver J. The role of nod mice in type 1 diabetes research: Lessons from the past and recommendations for the future. Front Endocrinol 2018; 9:51.

Yurkovetskiy L, Burrows M, Khan AA, Graham L, et al. Gender bias in autoimmunity is influenced by microbiota. Immunity 2013;39(2):400-12.